Total Payments
$15,163
2024 Payments
$1,791
Companies
61
Transactions
842
Medicare Patients
4,396
Medicare Billing
$495,320
Payment Breakdown by Category
Food & Beverage$15,099 (99.6%)
Education$63.42 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,099 | 836 | 99.6% |
| Education | $63.42 | 6 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,514 | 67 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,207 | 58 | $0 (2024) |
| Novo Nordisk Inc | $1,093 | 67 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,069 | 62 | $0 (2024) |
| ABBVIE INC. | $1,050 | 63 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,039 | 74 | $0 (2024) |
| Lilly USA, LLC | $986.16 | 53 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $554.68 | 34 | $0 (2023) |
| PFIZER INC. | $502.70 | 36 | $0 (2024) |
| Merck Sharp & Dohme LLC | $486.13 | 32 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,791 | 98 | Lilly USA, LLC ($278.81) |
| 2023 | $1,821 | 93 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($232.52) |
| 2022 | $1,458 | 70 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($226.39) |
| 2021 | $1,852 | 97 | AbbVie Inc. ($275.70) |
| 2020 | $1,477 | 84 | AstraZeneca Pharmaceuticals LP ($219.08) |
| 2019 | $2,394 | 130 | Amgen Inc. ($301.49) |
| 2018 | $2,095 | 126 | Novo Nordisk Inc ($216.65) |
| 2017 | $2,275 | 144 | Boehringer Ingelheim Pharmaceuticals, Inc. ($298.36) |
All Payment Transactions
842 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: NEUROSCIENCE | ||||||
| 12/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.86 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $27.42 | General |
| Category: VACCINES | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: VACCINES | ||||||
| 12/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $6.40 | General |
| Category: Diabetes | ||||||
| 12/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $4.88 | General |
| Category: Diabetes | ||||||
| 12/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $4.32 | General |
| Category: Diabetes | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $2.04 | General |
| Category: Gastroenterology | ||||||
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: DIABETES | ||||||
| 12/04/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Gastroenterology | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $5.28 | General |
| Category: Gastroenterology | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $1.94 | General |
| Category: Gastroenterology | ||||||
| 11/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: Biological | ||||||
| 11/06/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $27.68 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Gastroenterology | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $1.94 | General |
| Category: Gastroenterology | ||||||
| 11/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $2.23 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Gastroenterology | ||||||
| 10/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Gastroenterology | ||||||
| 10/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $1.56 | General |
| Category: Gastroenterology | ||||||
| 10/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Obesity | ||||||
| 10/16/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,090 | 2,003 | $281,240 | $135,588 |
| 2022 | 20 | 1,057 | 1,824 | $268,200 | $127,755 |
| 2021 | 20 | 1,064 | 1,881 | $265,044 | $125,838 |
| 2020 | 22 | 1,185 | 1,898 | $239,021 | $106,139 |
Total Patients
4,396
Total Services
7,606
Medicare Billing
$495,320
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 112 | 372 | $92,950 | $40,271 | 43.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 78 | 186 | $27,900 | $14,426 | 51.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 77 | 77 | $17,250 | $11,740 | 68.1% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 61 | 62 | $24,650 | $11,594 | 47.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 61 | 62 | $36,670 | $11,475 | 31.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 56 | 86 | $10,750 | $7,051 | 65.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 30 | 96 | $8,160 | $5,586 | 68.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 60 | 60 | $5,700 | $4,316 | 75.7% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 17 | 90 | $6,750 | $4,098 | 60.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 13 | 13 | $4,425 | $3,678 | 83.1% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 13 | 89 | $6,125 | $3,307 | 54.0% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 13 | 59 | $5,015 | $2,895 | 57.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 22 | 24 | $4,200 | $2,872 | 68.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 63 | 63 | $3,945 | $2,267 | 57.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 95 | 261 | $3,915 | $2,192 | 56.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 69 | 69 | $3,450 | $1,523 | 44.1% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 30 | 37 | $2,775 | $1,493 | 53.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 92 | 103 | $6,485 | $1,348 | 20.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 19 | 78 | $3,900 | $1,020 | 26.2% |
| 77085 | Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | Office | 2023 | 13 | 13 | $1,950 | $819.00 | 42.0% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 13 | 13 | $1,950 | $606.45 | 31.1% |
| 90471 | Administration of vaccine | Office | 2023 | 16 | 18 | $890.00 | $348.30 | 39.1% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 18 | 19 | $475.00 | $307.80 | 64.8% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 11 | 11 | $550.00 | $213.07 | 38.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 38 | 42 | $410.00 | $143.22 | 34.9% |
About Dr. David Edelson, MD
Dr. David Edelson, MD is a Internal Medicine healthcare provider based in Great Neck, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568440485.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Edelson, MD has received a total of $15,163 in payments from pharmaceutical and medical device companies, with $1,791 received in 2024. These payments were reported across 842 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($15,099).
As a Medicare-enrolled provider, Edelson has provided services to 4,396 Medicare beneficiaries, totaling 7,606 services with total Medicare billing of $495,320. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Great Neck, NY
- Active Since 01/03/2006
- Last Updated 11/18/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1568440485
Products in Payments
- XIFAXAN (Drug) $1,114
- JARDIANCE (Drug) $838.17
- FARXIGA (Drug) $834.51
- Otezla (Drug) $541.37
- MOUNJARO (Drug) $470.66
- Ozempic (Drug) $447.07
- EVENITY (Biological) $435.05
- TRULICITY (Drug) $385.92
- UBRELVY (Drug) $327.98
- Trintellix (Drug) $315.09
- CONTRAVE (Drug) $304.21
- XARELTO (Drug) $303.86
- TRINTELLIX (Drug) $291.30
- Saxenda (Drug) $281.54
- Aimovig (Biological) $264.96
- Belviq (Drug) $263.24
- Vascepa (Drug) $260.86
- TRADJENTA (Drug) $257.26
- Synthroid (Drug) $247.17
- PRALUENT (Drug) $237.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Great Neck
Dr. Jamie Hirsch, Md, MD
Internal Medicine — Payments: $69,165
Internal Medicine $69,165
Joanne Lee, M.d, M.D
Internal Medicine — Payments: $36,469
Internal Medicine $36,469
Bernard Rosof
Internal Medicine — Payments: $26,679
Internal Medicine $26,679
Dr. Shahram Shamekh, Md, MD
Internal Medicine — Payments: $18,187
Internal Medicine $18,187
Sanford Ratner, M.d, M.D
Internal Medicine — Payments: $16,933
Internal Medicine $16,933
William Klein, Md, MD
Internal Medicine — Payments: $14,297
Internal Medicine $14,297